Sign in to our library of over $5 million worth of researchclose

Two Quick Steps

* Required Fields

Click Your Industry



Registered Customers

If you have an account with us, please log in.

* Required Fields



Subscribe today
Sign in to our library of over $5 million worth of researchclose

Two Quick Steps

* Required Fields

Click Your Industry



Registered Customers

If you have an account with us, please log in.

* Required Fields



Subscribe today

We deliver Mobile Wallet Market Research and SWOT Analysis from Alternative Energy to Pharmaceuticals and Healthcare Market Research Reports to Digital Media.

Skip to Main Content »

Search Site
Researchers Currently Online:2080

Immune Thombocytopenic Purpura (ITP) Global Clinical Trials Review, Q2, 2011

Immune Thombocytopenic Purpura (ITP) Global Clinical Trials Review, Q2, 2011

Double click on above image to view full picture

Zoom Out
Zoom In
Additional Information
Price $1,000.00
Meta Description Immune Thombocytopenic Purpura (ITP) Global Clinical Trials Review, Q2, 2011

Summary

GlobalData's clinical trial report,
Publisher GlobalData
Date of Report Jun 15, 2011
Quick Overview
Immune Thombocytopenic Purpura (ITP) Global Clinical Trials Review, Q2, 2011

Summary

GlobalData's clinical trial report, “Immune Thombocytopenic Purpura (ITP) Global Clinical Trials Review, Q2, 2011" provides data on the Immune Thombocytopenic Purpura (ITP) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Immune Thombocytopenic Purpura (ITP). It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Immune Thombocytopenic Purpura (ITP). This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Table of Contents
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 6
Introduction 7
Immune Thombocytopenic Purpura (ITP) 7
Report Guidance 7
Clinical Trials by Region 8
Clinical Trials by Country 9
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 12
Top Five Countries Contributing to Clinical Trials in Europe 13
Top Countries Contributing to Clinical Trials in North America 14
Top Countries Contributing to Clinical Trials in Middle East and Africa 15
Top Countries Contributing to Clinical Trials in Central and South America 16
Clinical Trials by BRIC Nations 17
Clinical Trials by Phase 18
In Progress Trials by Phase 19
Clinical Trials by Trial Status 20
Unaccomplished Trials of Immune Thombocytopenic Purpura (ITP) 21
Subjects Recruited Over a Period of Time 24
Prominent Sponsors 25
Top Companies Participating in Immune Thombocytopenic Purpura (ITP) Therapeutics Clinical Trials 27
Prominent Drug Comparison 29
Clinical Trial Profiles 30
Clinical Trial Overview of Top Companies 30
GlaxoSmithKline plc 30
Clinical Trial Overview of GlaxoSmithKline plc 30
Amgen Inc. 31
Clinical Trial Overview of Amgen Inc. 31
Eisai Inc. 32
Clinical Trial Overview of Eisai Inc. 32
F. Hoffmann-La Roche Ltd. 33
Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 33
Grifols, S.A. 34
Clinical Trial Overview of Grifols, S.A. 34
Baxter Healthcare Corporation 35
Clinical Trial Overview of Baxter Healthcare Corporation 35
AstraZeneca PLC 36
Clinical Trial Overview of AstraZeneca PLC 36
Genzyme Corporation 37
Clinical Trial Overview of Genzyme Corporation 37
Protalex, Inc. 38
Clinical Trial Overview of Protalex, Inc. 38
CSL Limited 39
Clinical Trial Overview of CSL Limited 39
Ligand Pharmaceuticals, Inc. 40
Clinical Trial Overview of Ligand Pharmaceuticals, Inc. 40
IMMUNOMEDICS, INC 41
Clinical Trial Overview of IMMUNOMEDICS, INC 41
Talecris Biotherapeutics Holdings Corp 42
Clinical Trial Overview of Talecris Biotherapeutics Holdings Corp 42
Octapharma AG 43
Clinical Trial Overview of Octapharma AG 43
Symphogen A/S 44
Clinical Trial Overview of Symphogen A/S 44
Clinical Trial Overview of Top Universities / Institutes / Hospitals 45
Weill Cornell Medical College 45
Clinical Trial Overview of Weill Cornell Medical College 45
University of Alabama at Birmingham 46
Clinical Trial Overview of University of Alabama at Birmingham 46
Hadassah Medical Organization 47
Clinical Trial Overview of Hadassah Medical Organization 47
Assistance Publique - Hopitaux de Paris 48
Clinical Trial Overview of Assistance Publique - Hopitaux de Paris 48
St George Medical Research Foundation 49
Clinical Trial Overview of St George Medical Research Foundation 49
Ostfold Hospital Trust 50
Clinical Trial Overview of Ostfold Hospital Trust 50
Winthrop-University Hospital 51
Clinical Trial Overview of Winthrop-University Hospital 51
Hospital Universitario "Dr. Jose E. Gonzalez" 52
Clinical Trial Overview of Hospital Universitario "Dr. Jose E. Gonzalez" 52
Gruppo Italiano Malattie EMatologiche dell'Adulto 53
Clinical Trial Overview of Gruppo Italiano Malattie EMatologiche dell'Adulto 53
Mahidol University 54
Clinical Trial Overview of Mahidol University 54
Mayo Clinic 55
Clinical Trial Overview of Mayo Clinic 55
Sanquin Blood Supply Foundation 56
Clinical Trial Overview of Sanquin Blood Supply Foundation 56
Aarhus University 57
Clinical Trial Overview of Aarhus University 57
Bio Products Laboratory 58
Clinical Trial Overview of Bio Products Laboratory 58
Copenhagen University Hospital at Herlev 59
Clinical Trial Overview of Copenhagen University Hospital at Herlev 59
Assistance Publique Hopitaux De Marseille 60
Clinical Trial Overview of Assistance Publique Hopitaux De Marseille 60
Gunma University 61
Clinical Trial Overview of Gunma University 61
University Hospital, Toulouse 62
Clinical Trial Overview of University Hospital, Toulouse 62
University Hospital, Angers 63
Clinical Trial Overview of University Hospital, Angers 63
The Hospital for Sick Children 64
Clinical Trial Overview of The Hospital for Sick Children 64
Appendix 65
Abbreviations 65
Definitions 65
Research Methodology 66
Secondary Research 66
About GlobalData 67
Contact Us 67
Disclaimer 67
Source 68




...